Exchange: NASDAQ·Updated 07:30 PM EDT
LTRN logo

LTRN Lantern Pharma Inc

$0.6714
$0.0271
(4.05%)
Today
Closed $0.6413
$0.0301
(4.69%)
After Hours
EarningsNov 11
Mkt Cap$9.98M
Vol105,811.00

About LTRN

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
37

Bearish Sentiment

How do you feel about LTRN?

BabetteCH
$LTRN Empery reduced by 42%!!! Wait, what did Lane (Empery founder, CIO) say? „withZeta.AI continues to be our preferred platform for AI-assisted biopharma due diligence and research“. Come on… 🤣😂
2
BabetteCH
$LTRN let‘s reverse split 😂🤣😂🤣! IMO Sharma has no LP-300 Partnering, no OMAI-financing, nothing!!
2
AtariLynx
$LTRN Lantern Pharma Inc - Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC
1
3
Mack_The_Ripper
$LTRN an offering at $1.09, then a delisting notice. This guy sharma talked this shit up with the ai tool and spin off. So far, he’s done the opposite of what he said he would which was to create shareholder value. He has lost some credibility.
1
2
SevenPhigs27
$LTRN The one thing I hold on to is the tight capital structure. They will only have 17-18MM shares outstanding fully dilutive which no biotech can remotely be anywhere in the ballpark with all the trials and 2 subsidiaries. No where.
1
2
AtariLynx
$LTRN Not long to go now! Have you checked that your headphones are working properly? You have to listen very well! 😬
1
1
Kosmokrat
$LTRN Back in August I said it's too risky. I said they will do diluting capital injections, and the next one won't bring them to cash flow positive, so will need more. Many more. Looks like I was right. It's kind of sad, but biotech is a harsh environment now. It will be difficult for newcomers to raise enough capital to bring their drugs to market. I really hope for good trial results for $LTRN so their SP will do a big jump to the upside.
1
1
AtariLynx
$LTRN Whether there are gains or losses, it is sad to see LANTERN at this valuation because I still think it’s a “sleeping giant”. I really hope the green road taken this week is the road to back to a decent value, waiting for great news.
4
SevenPhigs27
$LTRN I can't get into the head of the CEO but the board knew of all of this. They did the miminal direct offering, IMO, or they could have unloaded. Maybe I'm crazy.
1
1
wells3600
$LTRN all fast track drug approvals on all they LTRN have, last year guy at FDA said on CNBC any new drugs the companies get 100 million each drug Trump made the deal what the guy said. I been waiting.. I want MONEY!!!
1
1
SevenPhigs27
$LTRN So far I'm wrong. I'll be the first to admit it. They had the ATM so I'm still wondering.
1
1
Stock_Catcher
$LTRN Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas
4
annapurna789
$LTRN Taking a small punt here. The beat down seems a bit over done, given their pipeline and AI platform.
3
GJ_Rockabilt
$LTRN How important will LTRN Artificial Intelligence be, once other Companies transition into Quantum assisted AI? Just wondering... I have no $LTRN Positions, but bullish to a point.
3
DarthVestor
$LTRN I hope the board of LTRN comes on these threads and see what fucking POS losers they are. Seriously down over 20kk with this fn pos company.
2
Nimrod44
$LTRN $CMPX $IMNN We can whine about them pos CEO’s or we can turn it against them and make our money anyways. The grass is always green if you learn to go with the flow.
2
Mack_The_Ripper
$LTRN after watching the video of them at "think Equity": the drug pipeline looks promising. The AI tool and spin off to me are questionable. I don't beleive this bum sharma. And sharma has the charm and charisma of a wet sock. the presentation was very low energy. There is also a video from a few weeks ago where he walks through the AI tool. i found it to be underwhelming as well. I think this stock is unfairly beaten down based on the drug pipeline. The current price IMO is based on CEO risk. He strikes me as incompetent and untrustworthy.
1
Mack_The_Ripper
$LTRN its not looking good. CEO has a poor track record, has been a disaster in this one so far. Now he’s got trouble with the nasdaq listing with the low market cap and price under a dollar. I also think he’s dishonest. We’d be better off with competent management. I have not decided on the shares. Hate to dump them at these prices. But very disappointed with this ugly fat fuck of a ceo.
1
BabetteCH
$LTRN The SEC will come knocking. Those recent statements went far beyond mere forward-looking statements.
1
BrassTax
$LTRN sold this stinker after that cnbc pump a couple years ago. Panna’s had a checkered past. Reverse split coming next year.
1

Advertisement|Remove ads.